SCHEMBL6948779

SCHEMBL6948779

O=[N+]([O-])c1c(Cl)ncnc1N1CCc2ccccc2CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
RPS6KB1 P23443 3/20 0.49
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
CUL4A Q13619 1/20 0.46
MAPT P10636 5/20 0.40
LMNA P02545 4/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
AURKA O14965 1/20 0.39
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6949468 0.84 HTT (0.52) HTTSMN1; SMN2RPS6KB1KMT2AMEN1
SCHEMBL6947729 0.84 HTT (0.73) HTTSMN1; SMN2RPS6KB1KMT2AMEN1
SCHEMBL16071246 0.83 SMN1; SMN2 (0.76) HTTSMN1; SMN2RPS6KB1KMT2AMEN1
SCHEMBL30623376 0.83 CUL4A (0.59) HTTRPS6KB1CUL4AMAPTLMNA
SCHEMBL28644797 0.83 CUL4A (0.59) HTTRPS6KB1CUL4AMAPTLMNA
SCHEMBL30623383 0.81 CUL4A (0.57) HTTRPS6KB1CUL4AMAPTLMNA
SCHEMBL28650731 0.81 CUL4A (0.57) HTTRPS6KB1CUL4AMAPTLMNA
SCHEMBL6947517 0.81 MEN1 (0.44) HTTSMN1; SMN2KMT2AMEN1MAPT
SCHEMBL6949967 0.81 HTT (0.49) HTTSMN1; SMN2RPS6KB1KMT2AMEN1
SCHEMBL6949507 0.81 HTT (0.49) HTTSMN1; SMN2RPS6KB1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed